DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Pill-form GLP-1 medications — no injections.

Eli Lilly oral tirzepatide for weight loss (Apr 2026 launch)

First FDA-approved oral semaglutide for weight loss (Jan 2026)

Oral semaglutide for type 2 diabetes (FDA-approved 2019)